# Trex Co Inc: financial statements, quarterly

TREX · NYSE · CIK 1069878 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/trex.md) · [Financials](/companies/trex/financials.md) · [Filings](/companies/trex/filings.md) · [Insiders](/companies/trex/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/trex/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [304](/filings/0000950170-24-117783.md) | [196 d](/filings/0001193125-26-068732.md) | [374](/filings/0000950170-25-067195.md) | [376](/filings/0000950170-25-102135.md) | [234](/filings/0001193125-25-264987.md) | [168](/filings/0001193125-26-068732.md) | [340](/filings/0001193125-26-211927.md) | [388](/filings/0001193125-26-332813.md) | [285](/filings/0001193125-25-264987.md) | [161 d](/filings/0001193125-26-068732.md) | [343](/filings/0001193125-26-211927.md) | [418](/filings/0001193125-26-332813.md) |
| Cost of revenue | $m | [173](/filings/0000950170-24-117783.md) | [127 d](/filings/0001193125-26-068732.md) | [204](/filings/0000950170-25-067195.md) | [208](/filings/0000950170-25-102135.md) | [141](/filings/0001193125-25-264987.md) | [96.7](/filings/0001193125-26-068732.md) | [202](/filings/0001193125-26-211927.md) | [230](/filings/0001193125-26-332813.md) | [170](/filings/0001193125-25-264987.md) | [112 d](/filings/0001193125-26-068732.md) | [204](/filings/0001193125-26-211927.md) | [260](/filings/0001193125-26-332813.md) |
| Gross profit | $m | [131](/filings/0000950170-24-117783.md) | [69.0 d](/filings/0001193125-26-068732.md) | [170](/filings/0000950170-25-067195.md) | [168](/filings/0000950170-25-102135.md) | [93.2](/filings/0001193125-25-264987.md) | [71.0](/filings/0001193125-26-068732.md) | [138](/filings/0001193125-26-211927.md) | [158](/filings/0001193125-26-332813.md) | [115](/filings/0001193125-25-264987.md) | [48.7 d](/filings/0001193125-26-068732.md) | [139](/filings/0001193125-26-211927.md) | [158](/filings/0001193125-26-332813.md) |
| Selling, general and administrative | $m | [44.5](/filings/0000950170-24-117783.md) | [42.5 d](/filings/0001193125-26-068732.md) | [50.6](/filings/0000950170-25-067195.md) | [51.2](/filings/0000950170-25-102135.md) | [38.9](/filings/0001193125-25-264987.md) | [39.3](/filings/0001193125-26-068732.md) | [56.1](/filings/0001193125-26-211927.md) | [55.7](/filings/0001193125-26-332813.md) | [45.0](/filings/0001193125-25-264987.md) | [45.2 d](/filings/0001193125-26-068732.md) | [55.5](/filings/0001193125-26-211927.md) | [67.5](/filings/0001193125-26-332813.md) |
| Operating income | $m | [86.4](/filings/0000950170-24-117783.md) | [26.5 d](/filings/0001193125-26-068732.md) | [119](/filings/0000950170-25-067195.md) | [117](/filings/0000950170-25-102135.md) | [54.3](/filings/0001193125-25-264987.md) | [31.7](/filings/0001193125-26-068732.md) | [81.7](/filings/0001193125-26-211927.md) | [102](/filings/0001193125-26-332813.md) | [70.4](/filings/0001193125-25-264987.md) | [3.5 d](/filings/0001193125-26-068732.md) | [83.5](/filings/0001193125-26-211927.md) | [86.2](/filings/0001193125-26-332813.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [21.8](/filings/0000950170-24-117783.md) | [8.4 d](/filings/0001193125-26-068732.md) | [29.9](/filings/0000950170-25-067195.md) | [29.9](/filings/0000950170-25-102135.md) | [13.8](/filings/0001193125-25-264987.md) | [9.9](/filings/0001193125-26-068732.md) | [21.2](/filings/0001193125-26-211927.md) | [26.6](/filings/0001193125-26-332813.md) | [18.6](/filings/0001193125-25-264987.md) | [1.2 d](/filings/0001193125-26-068732.md) | [22.1](/filings/0001193125-26-211927.md) | [22.0](/filings/0001193125-26-332813.md) |
| Net income | $m | [65.3](/filings/0000950170-24-117783.md) | [20.7 d](/filings/0001193125-26-068732.md) | [89.1](/filings/0001193125-25-264987.md) | [87.0](/filings/0001193125-25-264987.md) | [40.6](/filings/0001193125-25-264987.md) | [21.8](/filings/0001193125-26-068732.md) | [60.4](/filings/0001193125-26-332813.md) | [75.9](/filings/0001193125-26-332813.md) | [51.8](/filings/0001193125-25-264987.md) | [2.3 d](/filings/0001193125-26-068732.md) | [61.4](/filings/0001193125-26-332813.md) | [61.9](/filings/0001193125-26-332813.md) |
| Diluted EPS | $ per share | [0.60](/filings/0000950170-24-117783.md) | not reported | [0.82](/filings/0000950170-25-067195.md) | [0.80](/filings/0000950170-25-102135.md) | [0.37](/filings/0001193125-25-264987.md) | [0.20](/filings/0001193125-26-068732.md) | [0.56](/filings/0001193125-26-211927.md) | [0.71](/filings/0001193125-26-332813.md) | [0.48](/filings/0001193125-25-264987.md) | not reported | [0.58](/filings/0001193125-26-211927.md) | [0.60](/filings/0001193125-26-332813.md) |
| Basic EPS | $ per share | [0.60](/filings/0000950170-24-117783.md) | not reported | [0.82](/filings/0000950170-25-067195.md) | [0.80](/filings/0000950170-25-102135.md) | [0.37](/filings/0001193125-25-264987.md) | [0.20](/filings/0001193125-26-068732.md) | [0.56](/filings/0001193125-26-211927.md) | [0.71](/filings/0001193125-26-332813.md) | [0.48](/filings/0001193125-25-264987.md) | not reported | [0.58](/filings/0001193125-26-211927.md) | [0.60](/filings/0001193125-26-332813.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [4.6](/filings/0001193125-23-266276.md) | [2.0](/filings/0000950170-25-025780.md) | [3.1](/filings/0001193125-24-135380.md) | [1.2](/filings/0000950170-24-091989.md) | [12.8](/filings/0000950170-24-117783.md) | [1.3](/filings/0001193125-26-068732.md) | [5.0](/filings/0000950170-25-067195.md) | [5.5](/filings/0000950170-25-102135.md) | [11.4](/filings/0001193125-25-264987.md) | [3.8](/filings/0001193125-26-332813.md) | [4.5](/filings/0001193125-26-211927.md) | [6.5](/filings/0001193125-26-332813.md) |
| Current assets | $m | [273](/filings/0001193125-23-266276.md) | [172](/filings/0000950170-25-025780.md) | [513](/filings/0001193125-24-135380.md) | [434](/filings/0000950170-24-091989.md) | [353](/filings/0000950170-24-117783.md) | [369](/filings/0001193125-26-068732.md) | [592](/filings/0000950170-25-067195.md) | [453](/filings/0000950170-25-102135.md) | [338](/filings/0001193125-25-264987.md) | [310](/filings/0001193125-26-332813.md) | [580](/filings/0001193125-26-211927.md) | [478](/filings/0001193125-26-332813.md) |
| Total assets | $m | [997](/filings/0001193125-23-266276.md) | [933](/filings/0000950170-25-025780.md) | [1,293](/filings/0001193125-24-135380.md) | [1,270](/filings/0000950170-24-091989.md) | [1,267](/filings/0000950170-24-117783.md) | [1,374](/filings/0001193125-26-068732.md) | [1,641](/filings/0000950170-25-067195.md) | [1,538](/filings/0000950170-25-102135.md) | [1,452](/filings/0001193125-25-264987.md) | [1,453](/filings/0001193125-26-332813.md) | [1,730](/filings/0001193125-26-211927.md) | [1,626](/filings/0001193125-26-332813.md) |
| Current liabilities | $m | [182](/filings/0001193125-23-266276.md) | [91.1](/filings/0000950170-25-025780.md) | [369](/filings/0001193125-24-135380.md) | [244](/filings/0000950170-24-091989.md) | [251](/filings/0000950170-24-117783.md) | [342](/filings/0001193125-26-068732.md) | [602](/filings/0000950170-25-067195.md) | [419](/filings/0000950170-25-102135.md) | [282](/filings/0001193125-25-264987.md) | [251](/filings/0001193125-26-332813.md) | [566](/filings/0001193125-26-211927.md) | [450](/filings/0001193125-26-332813.md) |
| Total liabilities | $m | [305](/filings/0001193125-23-266276.md) | [216](/filings/0000950170-25-025780.md) | [489](/filings/0001193125-24-135380.md) | [375](/filings/0000950170-24-091989.md) | [379](/filings/0000950170-24-117783.md) | [487](/filings/0001193125-26-068732.md) | [731](/filings/0000950170-25-067195.md) | [549](/filings/0000950170-25-102135.md) | [410](/filings/0001193125-25-264987.md) | [419](/filings/0001193125-26-332813.md) | [734](/filings/0001193125-26-211927.md) | [616](/filings/0001193125-26-332813.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [692](/filings/0000950170-24-117783.md) | [742](/filings/0001193125-26-068732.md) | [804](/filings/0001193125-25-264987.md) | [895](/filings/0001193125-25-264987.md) | [888](/filings/0001193125-25-264987.md) | [887](/filings/0001193125-26-332813.md) | [947](/filings/0001193125-26-332813.md) | [1,026](/filings/0001193125-26-332813.md) | [1,042](/filings/0001193125-25-264987.md) | [1,034](/filings/0001193125-26-332813.md) | [996](/filings/0001193125-26-332813.md) | [1,010](/filings/0001193125-26-332813.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [180 d](/filings/0000950170-24-117783.md) | [101 d](/filings/0001193125-26-068732.md) | [(174)](/filings/0000950170-25-067195.md) | [194 d](/filings/0000950170-25-102135.md) | [133 d](/filings/0001193125-25-264987.md) | [(8.5) d](/filings/0001193125-26-068732.md) | [(154)](/filings/0001193125-26-211927.md) | [250 d](/filings/0001193125-26-332813.md) | [197 d](/filings/0001193125-25-264987.md) | [65.5 d](/filings/0001193125-26-068732.md) | [(118)](/filings/0001193125-26-211927.md) | [214 d](/filings/0001193125-26-332813.md) |
| Capital expenditure | $m | [30.6 d](/filings/0000950170-24-117783.md) | [53.2 d](/filings/0001193125-26-068732.md) | [37.7](/filings/0000950170-25-067195.md) | [35.5 d](/filings/0000950170-25-102135.md) | [78.3 d](/filings/0001193125-25-264987.md) | [80.9 d](/filings/0001193125-26-068732.md) | [79.5](/filings/0001193125-26-211927.md) | [46.8 d](/filings/0001193125-26-332813.md) | [53.9 d](/filings/0001193125-25-264987.md) | [43.4 d](/filings/0001193125-26-068732.md) | [23.1](/filings/0001193125-26-211927.md) | [29.6 d](/filings/0001193125-26-332813.md) |
| Share repurchases | $m | [0.2 d](/filings/0000950170-24-117783.md) | [0.0 d](/filings/0001193125-26-068732.md) | [5.1](/filings/0000950170-25-067195.md) | [0.4 d](/filings/0000950170-25-102135.md) | [50.1 d](/filings/0001193125-25-264987.md) | [50.3 d](/filings/0001193125-26-068732.md) | [4.0](/filings/0001193125-26-211927.md) | [0.0 d](/filings/0001193125-26-332813.md) | [0.0 d](/filings/0001193125-25-264987.md) | [50.4 d](/filings/0001193125-26-068732.md) | [82.8](/filings/0001193125-26-211927.md) | [70.7 d](/filings/0001193125-26-332813.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [109](/filings/0001193125-24-135380.md) | [109](/filings/0000950170-24-091989.md) | [109](/filings/0000950170-24-117783.md) | [109](/filings/0000950170-25-067195.md) | [109](/filings/0000950170-25-102135.md) | [108](/filings/0001193125-25-264987.md) | [107](/filings/0001193125-26-068732.md) | [107](/filings/0001193125-26-211927.md) | [107](/filings/0001193125-26-332813.md) | [107](/filings/0001193125-25-264987.md) | [105](/filings/0001193125-26-211927.md) | [102](/filings/0001193125-26-332813.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 101,865,190 at 2026-07-16, from the cover of the [10-Q filed 2026-08-04](/filings/0001193125-26-332813.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.